SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SCPH | AZN | AMGN | GILD | GSK |
| Company | SC Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 5.68 | 206.60 | 372.01 | 150.58 | 59.87 |
| High | 5.71 | 206.80 | 377.00 | 153.26 | 60.03 |
| Low | 5.65 | 205.66 | 371.39 | 150.09 | 59.62 |
| Latest | 5.67 | 206.53 | 373.11 | 151.69 | 59.60 |
| Change | unch | +0.08 | -2.39 | +0.57 | -0.77 |
| % Change | unch | +0.04% | -0.64% | +0.38% | -1.28% |
| Volume | 10,898,600 | 234,144 | 238,609 | 815,148 | 374,342 |
| 20-Day Average Volume | 1,991,445 | 2,838,425 | 2,877,309 | 8,105,748 | 6,384,534 |
| Previous Close | 5.67 | 206.45 | 375.50 | 151.12 | 60.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.64 | 194.63 | 360.97 | 147.20 | 56.08 |
| 20-Day Raw Stochastic | 74.07% | 79.42% | 76.21% | 84.29% | 85.18% |
| 20-Day Relative Strength | 62.41 | 64.23 | 61.66 | 65.15 | 69.20 |
| Weighted Alpha | +45.57 | +48.54 | +31.98 | +50.40 | +74.92 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 64% Buy | 88% Buy | 96% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 09/29/25 | +1.00% since 02/12/26 | +2.11% since 02/12/26 | +0.89% since 02/12/26 | +2.07% since 02/12/26 |
| Low | 5.64 on 10/02/25 | 204.09 on 02/13/26 | 361.71 on 02/13/26 | 150.33 on 02/19/26 | 58.56 on 02/13/26 |
| High | 5.70 on 10/06/25 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +1.80% since 09/05/25 | +14.84% since 01/20/26 | +12.97% since 01/20/26 | +23.38% since 01/20/26 | +25.39% since 01/20/26 |
| Low | 5.57 on 09/09/25 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 47.77 on 01/21/26 |
| High | 5.70 on 10/06/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +42.82% since 07/03/25 | +16.47% since 11/20/25 | +11.26% since 11/20/25 | +22.54% since 11/20/25 | +29.58% since 11/20/25 |
| Low | 3.83 on 07/07/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 46.47 on 11/21/25 |
| High | 6.28 on 07/24/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +144.40% since 04/04/25 | +28.27% since 08/20/25 | +26.13% since 08/20/25 | +29.00% since 08/20/25 | +49.11% since 08/20/25 |
| Low | 1.94 on 04/09/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 6.28 on 07/24/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 302,200 | 323,550,432 | 202,420,032 | 187,491,552 | 124,037,000 |
| Shares Outstanding, K | 53,298 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 36,330,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -85,150,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 16,040,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -18,020,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 0.31 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 11/12/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.38 | 18.74 | 13.54 |